Research analysts at Sanford C. Bernstein initiated coverage on shares of CONVATEC GRP PL/ADR (OTCMKTS:CNVVY) in a research note issued on Tuesday, The Fly reports. The firm set an “underperform” rating on the stock.

OTCMKTS CNVVY traded down $0.14 during trading on Tuesday, reaching $10.14. 25,800 shares of the company’s stock were exchanged, compared to its average volume of 2,736. CONVATEC GRP PL/ADR has a fifty-two week low of $6.03 and a fifty-two week high of $10.78. The business has a 50 day moving average price of $9.32 and a 200-day moving average price of $8.13.

CONVATEC GRP PL/ADR Company Profile

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.

Featured Story: What is the return on assets formula?

The Fly

Receive News & Ratings for CONVATEC GRP PL/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONVATEC GRP PL/ADR and related companies with MarketBeat.com's FREE daily email newsletter.